Ivabradine to Prevent Anthracycline-induced Cardiotoxicity

Clinical trial NCT04030546 · UNKNOWN

Trial details

NCT number: NCT04030546
Sponsor: Vilnius University
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Patients With Cancer

Start date: 2019-06-01
Primary completion: 2020-06-01
Enrollment: 128

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.